Search - tctmd.com

Displaying 121 - 138 of 138

Sort: Relevancy | Date

News Industry News

Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex® Biliary RX Stent

October 18, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

July 27, 2011

News Daily News

Genetic Variant Predicts Revascularization, Disease Progression in Young MI Patients

July 13, 2011

News Daily News

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Leah Lawrence

May 26, 2011

News Industry News

Titanium-Nitride-Oxide Bio Active Technology in ACS Patients: Present and Future

May 18, 2011

News Industry News

A Prospective, Randomised and Multicentre Trial Comparing Titan2 Bio Active Stent (BAS) and Xience V Drug Eluting Stent (DES): The BASE-ACS Trial

May 17, 2011

News Daily News

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

Jason Kahn

May 05, 2011

News Daily News

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

April 25, 2011

News Daily News

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

Jason Kahn

April 11, 2011

News Daily News

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

L.A. McKeown

April 07, 2011

News Conference News

Endothelial Shear Stress Works as a PREDICTION Tool

April 05, 2011

News Daily News

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

L.A. McKeown

March 10, 2011

News Daily News

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

March 01, 2011

News Daily News

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

February 06, 2011

News Daily News

No Additional Improvements After Early Gains from Percutaneous Pulmonary Valve

February 01, 2011

News Daily News

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

January 18, 2011

News Daily News

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

November 11, 2008

Advertisement

Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex® Biliary RX Stent

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

Genetic Variant Predicts Revascularization, Disease Progression in Young MI Patients

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Titanium-Nitride-Oxide Bio Active Technology in ACS Patients: Present and Future

A Prospective, Randomised and Multicentre Trial Comparing Titan2 Bio Active Stent (BAS) and Xience V Drug Eluting Stent (DES): The BASE-ACS Trial

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

Endothelial Shear Stress Works as a PREDICTION Tool

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

No Additional Improvements After Early Gains from Percutaneous Pulmonary Valve

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content